Clinical Trial Update: Microlearning Application for Diabetes Prevention [NA]

View source ↗

Summary

A Stanford University clinical trial evaluating a microlearning app for diabetes prevention has been terminated; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Prediabetes

Snippet

Sponsor: Stanford University | Conditions: PreDiabetes, Elevated Blood Sugar | NA | Status: TERMINATED